Avidity Partners Management LP Quant / Systematic

CIK: 0001791827 · Show all filings

Period: Q4 2019 (Next →)

Filing Date: Jun 17, 2020

Total Value ($000): $158,691 (100.0% shares, 0.0% debt)

Holdings (33)

BAX BAXTER INTL INC 8.7%
Value ($000) $13,797 Shares 165,000 Est. Cost $73.38 Unrealized 0.0%
HCA HCA HEALTHCARE INC 5.8%
Value ($000) $9,268 Shares 62,700 Est. Cost $127.66 Unrealized 0.0%
VRTX VERTEX PHARMACEUTICALS INC 5.5%
Value ($000) $8,758 Shares 40,000 Est. Cost $202.38 Unrealized 0.0%
ABBV ABBVIE INC 5.2%
Value ($000) $8,323 Shares 94,000 Est. Cost $64.63 Unrealized 0.0%
MIRATI THERAPEUTICS INC 5.2%
Value ($000) $8,247 Shares 64,000 Est. Cost $128.86 Unrealized
ZBH ZIMMER BIOMET HLDGS INC 5.1%
Value ($000) $8,158 Shares 54,500 Est. Cost $131.26 Unrealized 0.0%
ESPR ESPERION THERAPEUTICS INC NE 4.9%
Value ($000) $7,776 Shares 130,400 Est. Cost $44.96 Unrealized 0.0%
EW EDWARDS LIFESCIENCES CORP 4.0%
Value ($000) $6,299 Shares 27,000 Est. Cost $78.09 Unrealized 0.0%
CI CIGNA CORP NEW 3.9%
Value ($000) $6,135 Shares 30,000 Est. Cost $167.70 Unrealized 0.0%
ASND ASCENDIS PHARMA A S 3.7%
Value ($000) $5,857 Shares 42,100 Est. Cost $139.12 Unrealized
AXONICS MODULATION TECH INC 3.6%
Value ($000) $5,764 Shares 208,000 Est. Cost $27.71 Unrealized
HORIZON THERAPEUTICS PUB LTD 3.4%
Value ($000) $5,430 Shares 150,000 Est. Cost $36.20 Unrealized
NEXTCURE INC 3.3%
Value ($000) $5,239 Shares 93,000 Est. Cost $56.33 Unrealized
CATALENT INC 3.3%
Value ($000) $5,180 Shares 92,000 Est. Cost $56.30 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 3.0%
Value ($000) $4,700 Shares 232,000 Est. Cost $9.21 Unrealized 0.0%
DYNAVAX TECHNOLOGIES CORP 2.8%
Value ($000) $4,462 Shares 780,000 Est. Cost $5.72 Unrealized
ABEONA THERAPEUTICS INC 2.7%
Value ($000) $4,333 Shares 1,325,000 Est. Cost $3.27 Unrealized
DXCM DEXCOM INC 2.6%
Value ($000) $4,156 Shares 19,000 Est. Cost $47.43 Unrealized 0.0%
MOMENTA PHARMACEUTICALS INC 2.5%
Value ($000) $3,946 Shares 200,000 Est. Cost $19.73 Unrealized
QURE UNIQURE NV 2.5%
Value ($000) $3,941 Shares 55,000 Est. Cost $54.91 Unrealized 0.0%
CHRS COHERUS BIOSCIENCES INC 2.4%
Value ($000) $3,862 Shares 214,500 Est. Cost $18.44 Unrealized 0.0%
KADMON HLDGS INC 2.4%
Value ($000) $3,760 Shares 830,000 Est. Cost $4.53 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 2.3%
Value ($000) $3,704 Shares 180,000 Est. Cost $16.67 Unrealized 0.0%
NBIX NEUROCRINE BIOSCIENCES INC 2.2%
Value ($000) $3,547 Shares 33,000 Est. Cost $104.70 Unrealized 0.0%
IMMUNOMEDICS INC 1.9%
Value ($000) $2,962 Shares 140,000 Est. Cost $21.16 Unrealized
EXAS EXACT SCIENCES CORP 1.8%
Value ($000) $2,867 Shares 31,000 Est. Cost $87.91 Unrealized 0.0%
NEOLEUKIN THERAPEUTICS INC 1.6%
Value ($000) $2,587 Shares 210,000 Est. Cost $12.32 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.5%
Value ($000) $2,310 Shares 54,000 Est. Cost $43.50 Unrealized 0.0%
MDGL MADRIGAL PHARMACEUTICALS INC 0.9%
Value ($000) $1,367 Shares 15,000 Est. Cost $96.98 Unrealized 0.0%
RCKT ROCKET PHARMACEUTICALS INC 0.4%
Value ($000) $683 Shares 30,000 Est. Cost $16.70 Unrealized 0.0%
SUNESIS PHARMACEUTICALS INC 0.3%
Value ($000) $473 Shares 1,400,000 Est. Cost $0.34 Unrealized
ARAVIVE INC 0.3%
Value ($000) $410 Shares 30,000 Est. Cost $13.67 Unrealized
RLMD RELMADA THERAPEUTICS INC 0.2%
Value ($000) $390 Shares 10,000 Est. Cost $28.22 Unrealized 0.0%